Copyright
©The Author(s) 2017.
World J Gastroenterol. Mar 7, 2017; 23(9): 1541-1551
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1541
Published online Mar 7, 2017. doi: 10.3748/wjg.v23.i9.1541
Table 2 Pseudopolyps and increased incidence of colorectal cancer
Ref. | Year of publication | IBD diagnosis | Format of study | Cancer risk |
Rutter et al[44] | 2004 | UC with CRC (n = 68) | Case-control study 1:2, documentation of PP | OR = 2.29; 95%CI: 1.28-4.11 |
Velayos et al[43] | 2006 | UC with CRC (n = 188) | Case-control study 1:1, history of PP | OR = 2.5; 95%CI: 1.4-4.6 |
Baars et al[57] | 2011 | UC (n = 113) | Case-control study 1:2 | RR = 1.92; 95%CI: 1.28 -2.88 |
CD (n = 58) | ||||
IC (n = 2) |
- Citation: Politis DS, Katsanos KH, Tsianos EV, Christodoulou DK. Pseudopolyps in inflammatory bowel diseases: Have we learned enough? World J Gastroenterol 2017; 23(9): 1541-1551
- URL: https://www.wjgnet.com/1007-9327/full/v23/i9/1541.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i9.1541